Reflections on ASH 2024: Transformative Breakthroughs in Hematology-Oncology The 66th American Society of Hematology (ASH) Annual Meeting, held from December 7-10 in San Diego and online, delivered on its promise of showcasing groundbreaking advancements in hematology and oncology. Cromos Pharma’s CEO Vlad Bogin attended this event and prepared his takeaways on the most exciting and impactful insights shared at the conference. ASH 2024 Read more
Exploring Türkiye’s Edge in Clinical Research: Insights into Hospital Systems and Regulatory Framework Featuring Seniz Sagol, Türkiye Country Head at Cromos Pharma The clinical research landscape in Türkiye is undergoing a dynamic transformation, offering a unique combination of opportunities and challenges for sponsors and stakeholders alike. With its well-established healthcare infrastructure, vast patient population, and a growing commitment to aligning with international standards, Türkiye is becoming an increasingly Read more
Clinical Research Focus. 35th Edition Discover the Transformative Role of AI in Clinical Trials As we look back at the groundbreaking innovations of 2024, AI has proven to be a game-changer in clinical research, redefining patient recruitment, protocol design, and drug discovery. From AI-generated digital twins to advanced patient recruitment tools, these developments are paving the way for faster, more Read more
Countdown to ASH 2024: What to Expect in Breakthroughs in Hematology-Oncology The 66th American Society of Hematology (ASH) Annual Meeting is almost here, from December 7-10 in San Diego and online! This year’s gathering will be packed with groundbreaking developments in hematology and oncology. Here’s a glimpse into some of the highly anticipated presentations from industry frontrunners—just a few among hundreds of exciting advancements that will Read more
